SCHEMBL4362415

SCHEMBL4362415

O=C(O)NC1CCCN(c2nc(NC3CCN(C(=O)Cc4ccccc4-c4ccccc4)C3)nc3ccccc23)C1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
OPRM1 P35372 1/20 0.37
OPRK1 P41145 1/20 0.37
OGFRL1 Q5TC84 1/20 0.37
BTK Q06187 1/20 0.36
MAPT P10636 1/20 0.35
CDK2 P24941 3/20 0.35
CCNA2 P20248 2/20 0.35
CDK7 P50613 2/20 0.35
CCNH P51946 2/20 0.35
MNAT1 P51948 2/20 0.35
CCNE2 O96020 1/20 0.35
CCNE1 P24864 1/20 0.35
TUBB4A P04350 1/20 0.34
TUBB P07437 1/20 0.34
TUBA3C P0DPH7 1/20 0.34
TUBA1B P68363 1/20 0.34
TUBA4A P68366 1/20 0.34
TUBB4B P68371 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12225483 0.90 HSD11B1 (0.41)
SCHEMBL2541309 0.90 DPP4 (0.39) MEN1KMT2AMAPTCDK2CCNA2
SCHEMBL12225482 0.90 DPP4 (0.39) MEN1KMT2AMAPTCDK2CCNA2
SCHEMBL2539907 0.86 PRKD1 (0.40) MEN1KMT2AOPRM1MAPTPIK3R1
SCHEMBL2532857 0.86 GBA1 (0.40) MEN1KMT2AMAPTCDK2CCNA2
SCHEMBL2532859 0.86 GBA1 (0.40) MEN1KMT2AMAPTCDK2CCNA2
SCHEMBL2539903 0.86 PRKD1 (0.40) MEN1KMT2AOPRM1MAPTPIK3R1
SCHEMBL2536979 0.85 TSHR (0.43) MEN1KMT2AMAPTPIK3R1PIK3CA
SCHEMBL2536983 0.85 TSHR (0.43) MEN1KMT2AMAPTPIK3R1PIK3CA
Hydrochloric Acid SCHEMBL2539271 0.85 PRKD1 (0.40) MEN1KMT2AOPRM1MAPTPIK3R1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090291940-A1 AMINOPYRROLIDINE COMPOUND TAISHO PHARMACEUTICAL CO., LTD. (JP) 2009-11-26 US disclosed
EP-2003131-A1 AMINOPYRROLIDINE COMPOUND Taisho Pharmaceutical Co. Ltd. (JP) 2008-12-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090291940-A1 AMINOPYRROLIDINE COMPOUND MC4R, MC5R, MC2R MEN1 1210/4885KMT2A 914/4885OPRM1 12/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.